Severe drug-induced anaphylaxis: Analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 7, 2013, Pages 929-937

  Renaudin, J M ^a,b   Beaudouin, E ^a,b   Ponvert, C ^b,c   Demoly, P ^b,d   Moneret Vautrin, D A ^a,b  

^a Hospital Emile DURKHEIM   (France)

^b Allergy Vigilance Network   (France)

^c Sick Children Hospital   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

drug anaphylaxis; IgEs; oral challenge; skin tests

Indexed keywords

ADRENALIN; AESCULUS HIPPOCASTANUM EXTRACT; AMOXICILLIN; ANESTHETIC AGENT; BENFLUOREX; CARBOXYMETHYLCELLULOSE; CEPHALOSPORIN; CHLORHEXIDINE; CLAVULANIC ACID; CLOBUTINOL; DEXCHLORPHENIRAMINE; ENOXAPARIN; HEPARIN CALCIUM; HYDROXOCOBALAMIN; INSULIN; LATEX; LISINOPRIL; MACROGOL; METHYLPREDNISOLONE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORAMIDOPYRINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OMEPRAZOLE; PARACETAMOL; PENICILLIN DERIVATIVE; PRISTINAMYCIN; QUINOLONE; TOSYLCHLORAMIDE SODIUM; UNINDEXED DRUG;

ADULT; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; BRONCHOSPASM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE; LABORATORY TEST; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN TEST;

DRUG ANAPHYLAXIS; IGES; ORAL CHALLENGE; SKIN TESTS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SKIN TESTS; SURVIVAL RATE; YOUNG ADULT;

EID: 84880252415     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12168     Document Type: Article

References (34)

1. Hunziker T, Künzi UP, Braunschweig S, Zehnder D, Hoigné R,. Comprehensive hospital drug monitoring (CHDM) adverse skin reactions, a 20-year survey. Allergy 1997; 52: 388-393.
2. Lazarou J, Pomeranz BH, Corey PN,. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
3. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329: 15-19.
4. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second national institute of allergy and infectious disease/food allergy and anaphylaxis network symposium. J. Allergy Clin Immunol 2006; 117: 391-397.
5. Moneret-Vautrin DA, Morisset M, Flabbée J, Beaudouin E, Kanny G,. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60: 443-451.
6. Pumphrey RS,. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-1150.
7. Liew WK, Williamson E, Tang ML,. Anaphylaxis fatalities and admissions in Australia. J All Clin Immunol 2009; 123: 434-442.
8. Van Der Klauw MM, Stricker BHC, Herings RMC, Cost WS, Valkenburg HA, Wilson JHP,. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993; 35: 400-408.
9. Thiessard F, Roux E, Miremont-Salame G, Fourrier-Reglat A, Haramburu F, Tuber-Bitter P, et al. Trends in spontaneous adverse drug reaction reports to the French Pharmacovigilance system (1986-2001). Drug Saf 2005; 28: 731-740.
10. Simons FE, Ardusso L, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol 2011; 127: 587-593.
11. Worm M, Timmermans F, Moneret-Vautrin DA, Muraro A, Malmheden-Yman I, Lövik M, et al. Towards a European registry of severe allergic reactions: current status of national registries and future needs. Allergy 2010; 65: 671-680.
12. Ring J, Behrendt H,. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol 1999; 17: 387-399.
13. Brockow K, Romano A, Blanca M, Ring J, Picheler W, Demoly P,. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
14. Moneret-Vautrin DA,. Skin tests for diagnosis of curare allergy. Ann Fr Anesth Reanim 2002; 21 (Suppl 1): 97-107.
15. Torres MJ, Blanca M, Fernandez J, Romano A, de Weck A, Aberer W, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961-972.
16. Demoly P,. Anaphylactic reactions-value of skin and provocation tests. Toxicology 2005; 209: 221-223.
17. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.
18. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly J,. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-1006.
19. Brockow K, Christiansen C, Kanny G, Clément O, Barbaud A, Bircher AJ, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005; 60: 150-158.
20. Falcao H, Lunet N, Gomes E, Cunha L, Barros H,. Drug allergy in university students from Porto, Portugal. Allergy 2003; 58: 1210.
21. Gomes E, Cardoso M, Praca F, Gomes L, Marino E, Demoly P,. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004; 34: 1597-1601.
22. Ponvert C, Perrin Y, Bados-Allierat A, Le Bourgeois M, Karila C, Delacourt C, et al. Allergy to beta lactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011; 22: 411-418.
23. Moneret-Vautrin DA, Mertes PM,. Anaphylaxis to general anesthetics. Chem Immunol Allergy 2010; 95: 180-189.
24. Beaudouin E, Kanny G, Blanloeil Y, Guilloux L, Renaudin JM, Moneret-Vautrin DA,. Anaphylactic shock induced by gadoterate meglumine. Allerg Immunol 2003; 35: 382-385.
25. Hasdenteufel F, Luyasu S, Renaudin JM, Paquay JL, Carbutti G, Beaudouin E, et al. Anaphylactic shock after first exposure to gadoterate meglumine: two cases reported. J Allergy Clin Immunol 2008; 121: 527-528.
26. Brockow K, Romano A, Aberer W, Bircher AJ, Barbaud A, Bonadona P, et al. for the ENDA and the EAACI Interest group on Drug hypersensitivity. Skin testing in patients with hypersensitivity reactions to iodinated contrast media-a European multicenter study. Allergy 2009; 64: 234-241.
27. Kvedariene V, Martins P, Rouanet L, Demoly P,. Diagnosis of iodinated contrast media hypersensitivity: results of a 6-year period. Clin Exp Allergy 2006; 36: 1072-1077.
28. Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, et al. Hypersensitivity to non steroidal anti-inflammatory drugs (NSAIDs)- classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011; 66: 818-829.
29. Caimmi S, Caimmi D, Bousquet PJ, Demoly P,. How can we better classify NSAID hypersensitivity reactions?-Validation from a large database Int Arch Allergy Immunol 2012; 159: 306-312.
30. Van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG,. Different risks for NSAID-induced anaphylaxis. Ann Pharmacother 2002; 36: 24-29.
31. Riemer AB, Gruber S, Pali-Schöll I, Kinaciyan T, Untersmayr E, Jensen-Jarolim E,. Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model. Clin Exp Allergy 2010; 40: 486-493.
32. Harrer A, Lang R, Grims R, Braitsch M, Hawranek T, Aberer W, et al. Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS One 2010; 5: e13707.
33. Kvedariene V, Bencherioua AM, Messaad D, Godard P, Bousquet J, Demoly P,. The accuracy of diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blind trial. Clin Exp Allergy 2002; 32: 1366-1369.
34. Rutkowski K, Nasser SM, Ewan PW,. Paracetamol hypersensitivity: clinical features, mechanism and role of specific IgE. Int Arch Allergy Immunol 2012; 159: 60-64.